Page last updated: 2024-08-23

etoposide and Anticipatory Vomiting

etoposide has been researched along with Anticipatory Vomiting in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ahn, BM; Baek, JH; Jeon, SB; Kim, DH; Kim, JG; Lee, KB; Moon, JH; Sohn, SK; Sung, WJ	1
Astoul, P; Boutin, C; Gouvernet, J; Irisson, M; Juin, P; Pignon, T; Ruggieri, S	1

Trials

2 trial(s) available for etoposide and Anticipatory Vomiting

Article	Year
Phase II trial of amsacrine plus intermediate-dose Ara-C (IDAC) with or without etoposide as salvage therapy for refractory or relapsed acute leukemia. Japanese journal of clinical oncology, 2005, Volume: 35, Issue:10 Topics: Adolescent; Adult; Aged; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Diarrhea; Drug Administration Schedule; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Nausea; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Salvage Therapy; Survival Rate; Treatment Outcome; Vomiting, Anticipatory	2005
Alternating chemotherapy and accelerated split-course irradiation in locally advanced nonsmall cell lung carcinoma. Cancer, 1999, May-15, Volume: 85, Issue:10 Topics: Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Disease Progression; Etoposide; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Radiotherapy; Survival Analysis; Treatment Outcome; Vomiting, Anticipatory	1999

Article

Year

Phase II trial of amsacrine plus intermediate-dose Ara-C (IDAC) with or without etoposide as salvage therapy for refractory or relapsed acute leukemia.

Japanese journal of clinical oncology, 2005, Volume: 35, Issue:10

Topics: Adolescent; Adult; Aged; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Diarrhea; Drug Administration Schedule; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Nausea; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Salvage Therapy; Survival Rate; Treatment Outcome; Vomiting, Anticipatory

2005

Alternating chemotherapy and accelerated split-course irradiation in locally advanced nonsmall cell lung carcinoma.

Cancer, 1999, May-15, Volume: 85, Issue:10

Topics: Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Disease Progression; Etoposide; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Radiotherapy; Survival Analysis; Treatment Outcome; Vomiting, Anticipatory

1999